Retrial Begins In Original Testosterone MDL Bellwether

By Diana Novak Jones (March 7, 2018, 9:21 PM EST) -- Attorneys for a man who had a heart attack while taking AbbVie Inc.'s testosterone replacement therapy product AndroGel opened the retrial of the man's claims against the pharmaceutical company Wednesday, telling an Illinois federal jury AbbVie didn't tell his doctor about the drug's risks....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!